Modeling the economic benefits of better TB vaccines

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 11, 2001, Pages 984-993

  Bishai, D M ^a   Mercer, D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Costs; Demand; Economics; Epidemiology; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE;

ABSENTEEISM; ARTICLE; BCG VACCINATION; CHILD; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DISABILITY; DRUG COST; DRUG EFFICACY; ECONOMIC ASPECT; HUMAN; INFECTION RISK; INVESTMENT; LUNG TUBERCULOSIS; MALE; MODEL; MONEY; PRIORITY JOURNAL; PRODUCTIVITY; PROFIT; RISK BENEFIT ANALYSIS;

ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CHILD; COST OF ILLNESS; COST SAVINGS; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS; VACCINATION;

EID: 0035208155     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Control strategies for tuberculosis epidemics: New models for old problems
2. Modeling the impact of global tuberculosis control strategies
3. The use of an epidemiological model for estimating the effectiveness of tuberculosis control measures
4. The death and resurrection of tuberculosis
5. Cost-benefit analysis of BCG vaccination under various epidemiological situations
6. Benefits and costs of the schools' BCG vaccination programme
7. Cost-benefit analysis of BCG-vaccination in Austria
8. A cost-benefit analysis of BCG revaccination in the Czech Republic
9. Potential impact of tuberculosis vaccines as epidemic control agents
10. An overview of the proceedings of the international symposium on tuberculosis vaccine development and evaluation: Recognizing and addressing the barriers
11. Current tuberculosis vaccine development
12. Economic impact of tuberculosis at the household level
13. An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda
14. Socioeconomic impact of tuberculosis on patients and family in India
15. Disease eradication: Private vs. public vaccination
16. The intrinsic transmission dynamics of tuberculosis epidemics
17. Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function
18. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project
19. Health-care expenditures for tuberculosis in the United States
20. Evaluation of a tuberculosis screening program for high-risk students in Toronto schools
21. Cost-comparison of different management policies for tuberculosis patients in Italy
22. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation
23. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries
24. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: Expereince from rural South Africa
25. Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: A theoretical model
26. Anti-tuberculosis programs in Thailand: A cost analysis
27. Costs and benefits of improving tuberculosis control: The case of Thailand
28. World Population Information
29. Global epidemiology of tuberculosis
30. Causes of low pre-school immunization coverage in the United States
31. Win-win interactions between the public and private sectors